This article first appeared on Forbes.com Speed to market has always been critical in the life sciences industry. Companies that bring products to market quickly and efficiently are better positioned to succeed and improve patient outcomes. Or so the industry wisdom goes. For Moderna, the covid wunderkind that captured almost $40 billion in sales over the […]